← Insider buys
SPRO

Spero Therapeutics, Inc. · Healthcare

Aquilo Capital Management, LLC sold $1.9M of Spero Therapeutics, Inc.

10% owner

Sold$1,901,987
$19.02Price
100,000Shares
−3%Stake

What SPRO did after the filing

Prices for SPRO after this filing aren't in yet.

Traded Mon, Feb 1. Filed Thu, Feb 4, 1:46 PM ET, during the session. Not investment advice.